61
Total investments
36
Early stage
11
Mid stage
4
Late stage
17y
Years active
Portfolio
58 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2026
We are a clinical-stage biopharmaceutical company spun out of the strategic combination of Beckley Psytech and Atai Life Sciences in 2025, advancing lead asset ELE-101. We develop patient-centered psychedelic treatments designed to fit the psychiatric care model and address unmet need in mental health.
Investor
Nov 2025
Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation.
As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.
Investor
May 2022
August is a lifestyle period care brand working to reimagine periods for everyone who menstruates. Follow along @itsaugust
Investor
Jan 2022
TURN ORIGINAL ARTWORK INTO NFTS
DISCOVER & BUY VERIFIED ART
EQUIPPED W/SCANNABLE NFC CHIPS
-PROOF OF OWNERSHIP
-TRADABILITY
-EXCLUSIVE CONTENT
Investor
Dec 2021
In the midst of the housing affordability crisis, Rhino is charging into the real estate space to unlock over $45 billion in cash security deposits. We are building products, like our affordable insurance policy, to put money back in renters pockets. The Rhino team is passionate about improving the quality of life for people everywhere by providing simple solutions for humanitys modern-day problems. We are looking to connect with talented and passionate people that share our vision to join our team.
Investor
Nov 2021
Kueski is the largest online consumer lender in Mexico, that provides financial services for users who are ineligible for traditional bank loans.
Thanks to its technology and data analysis criteria, the company has positioned itself as a market leader.
In 2016, Adalberto Flores, CEO and Co-founder of Kueski, was recognized as Mexican Entrepreneur of the Year by Endeavor.
Tuesday Capital, Victory Park Capital, Sobrato Family, Angel Ventures Mexico, Rise Capital, Core Ventures Group, Ariel Poler, Pedro Aspe, Bismarck Lepe, Variv Capital, David Begler, Endeavor Catalyst, and Auria Capital are among the companies betting on this project.
Check out the Jobs section to see all the open positions that we have, and enjoy the most creative, smart, disruptive and fun team that you could imagine.
Investor and Board Member
Oct 2021
A collective of scientists, developers and artists that aim to advance nutrition for the human and planetary health in every environment. Building the first scalable, circular farm-to-table model.
Investor
Oct 2021
MoonPay simplifies access to buy, sell and trade crypto using everyday payment methods like cards, Apple Pay, PayPal and Venmo, while also providing simple tools to send, receive and manage stablecoins.
Whether you are new to digital money or a company exploring new ways to use it, MoonPay provides the trusted infrastructure to onboard users into the blockchain-based financial ecosystem safely and seamlessly.
With 30 million customers and powering the infrastructure for nearly 500 companies across the decentralized economy, MoonPay is a key driver behind mainstream crypto adoption.
It is fully licensed in the U.S. and regulated in the UK, EU, Canada and Australia—and has been certified for its enterprise-grade security.
MoonPay is changing payments.
Investor
Oct 2021
Elo is the Smart Nutrition company turning food from the leading cause of disease to medicine by harnessing personalized nutrition, AI, and the power of at-home testing. Elo Smart Nutrition Platform empowers leading health and wellness brands to launch Smart Nutrition products to their millions of engaged customers, helping them live healthier lives.
Interested in launching Smart Nutrition products for your brand? Lets talk!
See our open positions at https://apply.workable.com/elo-health/.
Investor
Sep 2021
At Alt, we’re on a mission to unlock the value of alternative assets, and looking for talented people who share our vision.
Our platform enables users to sell, buy, value, and securely store their collectible cards. And we envision a world where anything is an investable asset.
Passionate about trading cards? Search our open roles!
Investor
Aug 2021
The brand that people trust not to upset their stomachs. BelliWelli for a Better Belly.
Investor
Jul 2021
Magic is an SDK that enables companies to create instant web3 wallets with a web2 login (email, social) to optimize user conversion on their app. Our solution abstracts away the complexities of wallets and removes the need for seed phrases, browser extensions, or downloads.
With enterprise-grade security and reliability, Magic gives companies peace of mind as their apps scale, all with just a few lines of code.
At Magic, our mission is to onboard a billion users to web3 by helping companies break down barriers to adoption.
Investor
Apr 2021
TRIPP is an award-winning digital wellness company developing transformative, immersive experiences that support relaxation, focus and productivity. In a nutshell, TRIPP is Fitness for Your Inner Self.
Investor
Apr 2021
Orbillion is a B2B cultivated meat technology company that brings commercially-viable meat to the ever-growing $211B global ground beef market. Orbillion has developed a game-changing algorithm for the scale-up of cultivated meat that makes commercializing low-cost cultivated beef possible. The Orbillion founders bring more than 35 years of combined experience in biopharma bioprocessing, optimizing the very systems required to commercialize cultivated meat. Orbillion is backed by The Venture Collective, Y Combinator, At One Ventures, Venture Souq, and Metaplanet. Learn more and partner with us at www.orbillion.com.
Show all 58 investments ↓
Experience · 67 entries
All (67)
Investments (60)
Founder (2)
Board (2)
2026
Investor
Jan 2026
We are a clinical-stage biopharmaceutical company spun out of the strategic combination of Beckley Psytech and Atai Life Sciences in 2025, advancing lead asset ELE-101. We develop patient-centered psychedelic treatments designed to fit the psychiatric care model and address unmet need in mental health.
2025
Investor
Nov 2025
Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation.
As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.
2022
Investor
May 2022
August is a lifestyle period care brand working to reimagine periods for everyone who menstruates. Follow along @itsaugust
Investor
Jan 2022
TURN ORIGINAL ARTWORK INTO NFTS
DISCOVER & BUY VERIFIED ART
EQUIPPED W/SCANNABLE NFC CHIPS
-PROOF OF OWNERSHIP
-TRADABILITY
-EXCLUSIVE CONTENT
2021
Investor
Dec 2021
In the midst of the housing affordability crisis, Rhino is charging into the real estate space to unlock over $45 billion in cash security deposits. We are building products, like our affordable insurance policy, to put money back in renters pockets. The Rhino team is passionate about improving the quality of life for people everywhere by providing simple solutions for humanitys modern-day problems. We are looking to connect with talented and passionate people that share our vision to join our team.
Show all 67 entries ↓
Investment activity
2009–2026 · 61 investments
Recent (last 2 years)Earlier